Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...

2019-05-23 20:00 2942

MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics

TOKYO, May 23, 2019 /PRNewswire/ -- MGI , a subsidiary of global genomics leader BGI Group, announced it will begin marketing a total solution for single cell RNA Sequencing as part of the 10x Genomics' Compatible Product Partner Program on MGI's MGISEQ and BGISEQ sequenci...

2019-05-23 19:02 2920

Phebra establishes new subsidiary in Canada and announces marketing approval for its IV Arsenic Trioxide Solution

SYDNEY, May 23, 2019 /PRNewswire/ -- Australian pharmaceutical firm Phebra (the 'Company') has continued its international business expansion with the opening of its subsidiary inMontreal, Canada. The new entity, Phebra Canada, will be headed byTony Romagnino, Vice President of Phebra's current N...

2019-05-23 17:00 1788

Tencent Miying Launches AI-supported Auxiliary Diagnostic System

KUNMING, China, May 22, 2019 /PRNewswire/ -- Tencent today announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held inKunming, China. This latest technology can rapidly identify the cervical transforma...

2019-05-23 04:47 7542

China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province

TAIZHOU, China, May 22, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today the laun...

2019-05-22 23:20 6990

Vitaeris Announces Multiple Scientific Presentations Involving Clazakizumab at the 2019 American Transplant Congress

- Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection - 8 Oral & Poster Presentations VANCOUVER, British Columbia, May 22, 2019 /PRNewswire/ -- Vitaeris Inc. (Vitaeris) today announced that eight abstracts involving or related to clazakizumab, Vitaeris' pro...

2019-05-22 20:30 1791

Scientists Identify New Therapeutic Target for Fatty Liver Disease

* Preclinical study highlights a novel therapy for the treatment of fatty liver disease, which affects up to 25% of the global population * Inhibiting interleukin 11 (IL11) signalling addresses multiple aspects of non-alcoholic steatohepatitis (NASH), including hepatic inflammation and fibros...

2019-05-22 18:24 1960

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis

ADELAIDE, Australia, May 22, 2019 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved for treating plaque psoriasis of the scalp and b...

2019-05-22 18:00 6571

GPHL's first overseas scholarship established in partnership with University of Auckland

AUCKLAND, New Zealand, May 21, 2019 /PRNewswire/ -- The recent Conference on Dialogue of Asian Civilizations has not just helped various civilizations flourish through dialogues and exchanges, but also drivenChina's national brands to integrate into the world with stronger cultural confidence. On...

2019-05-21 16:58 1963

GPHL's first overseas scholarship established in partnership with University of Auckland

Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress

11 Presentations – Including 4 Plenary Presentations – to Feature the Evoke System ARTARMON, Australia, May 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spin...

2019-05-20 16:00 1743

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and DALLAS, May 20, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical-stage biotech company developing novel therapeutics for areas with high unmet medical needs, announced that the company presented interim data from a Phase I clinical study on BBT-877, a drug c...

2019-05-20 08:38 1812

ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration

SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 16, 2019 /PRNewswire/ -- Shanghai ChemPartner a leading global Contract Research Organization (CRO), along withBerkeley Lights, Inc. (BLI) , the leader in digital cell biology, announced ...

2019-05-16 23:00 1775

Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results

WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...

2019-05-16 05:00 11013

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...

2019-05-15 20:13 1898

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results

HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2019-05-15 18:00 8359

Hong Kong Science Park Leads Start-Up Delegation to North America's Fastest Growing Technology Conference in Toronto

HONG KONG, May 15, 2019 /PRNewswire/ -- Hong Kong Science and Technology Parks Corporation ("HKSTP") today announced that it is leading a delegation of 14 start-ups to Collision, one ofNorth America's leading technology conference, to be held inToronto, Canada from May 20 - 23, 2019. Leveraging o...

2019-05-15 16:02 2167

Ortho Clinical Diagnostics to Host 4th Annual Hospital C-Suite Summit in Singapore

2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence RARITAN, New Jersey and SINGAPORE, May 14, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration withSingapore Management University, w...

2019-05-14 07:00 2687

AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, May 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has submitted a Special 510(k) pre-market notification to t...

2019-05-14 04:09 1111

China Biologic Reports Financial Results for the First Quarter of 2019

--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING, May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"...

2019-05-11 04:30 9549

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa

SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics,announced today an expansion of its ocular disease pipeline. Specifically, the company announced that OLX304A has been added to develop an RNAi therapeutic with...

2019-05-10 09:24 1558

1 ... 251 252 253254255